Physician profile
Jane E Salmon
NPI 1891848875
$62,967.80
in general payments reported to CMS, 2019-2025
4 companies · $25K in 2025
The $25K reported for 2025 was more than what 93% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,284 · 2020: $5,220 · 2021: $1,725 · 2022: $11K · 2023: $1,320 · 2024: $10K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Food and Beverage: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,126.61 |
| Food and Beverage | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb Sa | $46,124.61 | 2022-2025 | Cimzia |
| E.R. Squibb & Sons, L.L.C. | $8,377.32 | 2019-2020 | |
| Ucb, INC. | $7,883.87 | 2019-2025 | |
| Biocryst Pharmaceuticals, INC. | $582.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Salmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.